ARCHIVES

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

This article is from The Cancer Letter archive.

Vol. 34 No. 40 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984